Expression of the immune checkpoint biomarker PD-L1 and the receptor tyrosine kinase c-MET probes were also assessed microscopically in serial sections of the CRC TMAs and correlated to the level of expression of PPIB. This evidence concerns the gene MET and colorectal carcinoma.